Quality of Life and Metabolic Indicators of Patients with Type 2 Diabetes: A Cross-Sectional Study in Iran

Table 3

The relationship between metabolic indicators, demographic characteristics, physical activity, and HRQOL of participants.

Variables	Age	Gender^¢	Education level^¢	Duration of T2DM	Medication treatment of T2DM^¢	HRQOL	BMI	HDL	LDL	FBS	HbA1c	Total cholesterol	Triglyceride	Systolic BP	Diastolic BP	Physical activity
Age	1	0.21	−0.32	0.23	−0.07	−0.01	−0.17	−0.03	0.10	−0.12	0.07	−0.03	0.11	0.09	−0.02	−0.21
Gender^¢		1	0.18	0.02	−0.21	0.27	−0.11	−0.23	−0.04	−0.15	−0.17	−0.18	−0.11	0.16	0.14	0.16
Education level^¢			1	−0.11	−0.06	0.14	0.05	−0.12	−0.15	0.06	−0.11	−0.00	−0.17	0.00	0.00	0.34
Duration of T2DM				1	0.09	−0.09	−0.02	−0.00	−0.20	0.15	0.23	−0.19	0.01	0.06	−0.03	−0.14
Medication treatment of T2DM^¢					1	−0.04	−0.06	−0.10	−0.09	−0.00	−0.03	−0.07	−0.06	−0.08	−0.03	−0.00
HRQOL						1	−0.04	−0.21	−0.15	0.05	−0.01	−0.10	0.03	−0.09	−0.02	0.20
BMI							1	0.03	0.09	0.08	0.10	0.10	0.08	0.03	−0.01	−0.05
HDL								1	−0.00	0.12	0.06	0.25	0.11	0.03	0.04	−0.13
LDL									1	−0.02	0.17	0.42	0.09	0.02	0.09	−0.20
FBS										1	0.43	0.09	0.21	0.04	0.06	−0.09
HbA1c											1	0.08	0.07	0.01	0.14	−0.21
Total cholesterol												1	0.41	−0.06	0.02	−0.06
Triglyceride													1	0.07	0.05	−0.07
Systolic BP														1	0.61	−0.01
Diastolic BP															1	−0.04
Physical activity																1

T2DM: type 2 diabetes mellitus; HRQOL: Health-Related Quality of Life; BMI: body mass index; HDL: high-density lipoprotein; LDL: low-density lipoprotein; FBS: fasting blood sugar; BP: blood pressure. ^¢Spearman’s correlation analysis. Correlation is significant at 0.05 level. Correlation is significant at 0.01 level.